{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:57:17Z","timestamp":1793228237991,"version":"4.5.0"},"reference-count":237,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["75051"],"award-info":[{"award-number":["75051"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["40402778"],"award-info":[{"award-number":["40402778"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119529","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:45:50Z","timestamp":1781124350000},"page":"119529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Nanoparticle-based strategies for immune modulation and reorganization in the tumor microenvironment to combat cancer cells"],"prefix":"10.1016","volume":"200","author":[{"given":"Samira","family":"Azhdarifam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Metanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ghobeishavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Nouroloyouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Jahanban","family":"Esfahlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12951-022-01476-9","article-title":"Nanoparticles mediated tumor microenvironment modulation: current advances and applications","volume":"20","author":"Raju","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2026.119529_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118543","article-title":"Harnessing nanotechnology to modulate hypoxic tumor microenvironments: enhanced strategies for oncological innovations","volume":"191","author":"Ghassemifar","year":"2025","journal-title":"Biomed. & Pharmacother."},{"issue":"7","key":"10.1016\/j.biopha.2026.119529_bib3","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"issue":"7","key":"10.1016\/j.biopha.2026.119529_bib4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41401-020-0424-4","article-title":"Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment","volume":"41","author":"Sun","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2026.119529_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122899","article-title":"Nanoparticles in cancer theragnostic and drug delivery: a comprehensive review","volume":"352","author":"Al-Thani","year":"2024","journal-title":"Life Sci."},{"issue":"21","key":"10.1016\/j.biopha.2026.119529_bib6","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.3390\/nano13212887","article-title":"Application of nanoparticles in cancer treatment: a concise review","volume":"13","author":"Sell","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2026.119529_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jconrel.2021.07.009","article-title":"Manipulation of TAMs functions to facilitate the immune therapy effects of immune checkpoint antibodies","volume":"336","author":"Liu","year":"2021","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.biopha.2026.119529_bib8","doi-asserted-by":"crossref","first-page":"11740","DOI":"10.1021\/acsnano.8b05893","article-title":"Nanoparticle-mediated remodeling of the tumor microenvironment to enhance immunotherapy","volume":"12","author":"Musetti","year":"2018","journal-title":"ACS nano"},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13045-024-01535-8","article-title":"Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy","volume":"17","author":"Lu","year":"2024","journal-title":"J. Hematol. & Oncol."},{"key":"10.1016\/j.biopha.2026.119529_bib10","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2147\/IJN.S492713","article-title":"Nanoparticles modulating the immune microenvironment in breast cancer treatment","author":"Guo","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119529_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jconrel.2020.09.034","article-title":"Manipulating immune system using nanoparticles for an effective cancer treatment: combination of targeted therapy and checkpoint blockage miRNA","volume":"329","author":"Nguyen","year":"2021","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.biopha.2026.119529_bib12","first-page":"135","article-title":"Engineered exosome-based treatment for peripheral nerve regeneration: a narrative review of clinical prospects","volume":"2","author":"Yao","year":"2025","journal-title":"Adv. Technol. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib13","first-page":"78","article-title":"Endothelial progenitor cells and their secretome for stroke therapy: a narrative review","volume":"3","author":"Bayraktutan","year":"2026","journal-title":"Regen. Med. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2026.119529_bib14","first-page":"185","article-title":"Harnessing the immune system and developing targeted vaccines: overall strategies of leveraging the body\u2019s natural defense mechanisms to enhance cancer treatment","volume":"2","author":"Banday","year":"2025","journal-title":"Regen. Med. Rep."},{"key":"10.1016\/j.biopha.2026.119529_bib15","series-title":"Exploration","article-title":"Tumor cell membrane-based vaccines: a potential boost for cancer immunotherapy","author":"Yang","year":"2024"},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-022-00866-3","article-title":"Tumor microenvironment: barrier or opportunity towards effective cancer therapy","volume":"29","author":"Tiwari","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2026.119529_bib17","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.2147\/IJN.S321416","article-title":"Nanoparticle-mediated targeted drug delivery to remodel tumor microenvironment for cancer therapy","author":"Tang","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13046-025-03567-5","article-title":"Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers","volume":"44","author":"Weng","year":"2025","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41420-025-02566-x","article-title":"Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review","volume":"11","author":"Masuda","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2026.119529_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2025.102385","article-title":"Multifunctional nanoplatforms for tumor microenvironment remodeling: toward precision and intelligent cancer therapy","author":"Deng","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"15","key":"10.1016\/j.biopha.2026.119529_bib21","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1039\/D2BM00600F","article-title":"Combination of tumor vessel normalization and immune checkpoint blockade for breast cancer treatment via multifunctional nanocomplexes","volume":"10","author":"Zeng","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2026.119529_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.biopha.2026.119529_bib23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. & Mol. Immunol."},{"key":"10.1016\/j.biopha.2026.119529_bib24","series-title":"Seminars in cancer biology","article-title":"What are regulatory T cells (Treg) regulating in cancer and why?","author":"Whiteside","year":"2012"},{"issue":"6","key":"10.1016\/j.biopha.2026.119529_bib25","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.3390\/ijms26062716","article-title":"The role of the tumor microenvironment (TME) in advancing cancer therapies: immune system interactions, tumor-infiltrating lymphocytes (TILs), and the role of exosomes and inflammasomes","volume":"26","author":"Erasha","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119529_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613492","article-title":"Metabolism of dendritic cells in tumor microenvironment: for immunotherapy","volume":"12","author":"Peng","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119529_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41419-021-03579-x","article-title":"The role of PKM2 nuclear translocation in the constant activation of the NF-\u03baB signaling pathway in cancer-associated fibroblasts","volume":"12","author":"Gu","year":"2021","journal-title":"Cell death & Dis."},{"issue":"3","key":"10.1016\/j.biopha.2026.119529_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","article-title":"Cancer-associated fibroblasts in gastrointestinal cancer","volume":"16","author":"Kobayashi","year":"2019","journal-title":"Nat. Rev. Gastroenterol. & Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119529_bib30","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp. & Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.biopha.2026.119529_bib32","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"issue":"15","key":"10.1016\/j.biopha.2026.119529_bib33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2217\/nnm-2023-0088","article-title":"Modulation of cancer-associated fibroblasts by nanodelivery system to enhance efficacy of tumor therapy","volume":"18","author":"Ai","year":"2023","journal-title":"Nanomedicine"},{"issue":"9","key":"10.1016\/j.biopha.2026.119529_bib34","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","article-title":"NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors","volume":"80","author":"Ford","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119529_bib35","doi-asserted-by":"crossref","first-page":"S615","DOI":"10.1016\/j.annonc.2024.08.914","article-title":"853MO Setanaxib plus pembrolizumab for the treatment of recurrent or metastatic squamous cell carcinoma of the head & neck: Results of a randomized, double-blind phase II trial","volume":"35","author":"Fayette","year":"2024","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.349","article-title":"Signaling pathways in macrophages: molecular mechanisms and therapeutic targets","volume":"4","author":"Li","year":"2023","journal-title":"MedComm"},{"issue":"8","key":"10.1016\/j.biopha.2026.119529_bib37","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/eji.201444870","article-title":"STAT of the union: dynamics of distinct tumor-associated macrophage subsets governed by STAT1","volume":"44","author":"Van Overmeire","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-017-0430-2","article-title":"Tumor-associated macrophages: from basic research to clinical application","volume":"10","author":"Yang","year":"2017","journal-title":"J. Hematol. & Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119529_bib39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1158\/2326-6066.CIR-15-0170","article-title":"Post-sepsis state induces tumor-associated macrophage accumulation through CXCR4\/CXCL12 and favors tumor progression in mice","volume":"4","author":"Mota","year":"2016","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13045-016-0333-7","article-title":"Long non-coding RNAs in the regulation of myeloid cells","volume":"9","author":"Tian","year":"2016","journal-title":"J. Hematol. & Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib41","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4049\/jimmunol.164.2.762","article-title":"Autocrine production of IL-10 mediates defective IL-12 production and NF-\u03baB activation in tumor-associated macrophages","volume":"164","author":"Sica","year":"2000","journal-title":"J. Immunol."},{"issue":"46","key":"10.1016\/j.biopha.2026.119529_bib42","doi-asserted-by":"crossref","first-page":"75339","DOI":"10.18632\/oncotarget.12180","article-title":"The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization","volume":"7","author":"Finkernagel","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.biopha.2026.119529_bib43","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ccr.2011.02.005","article-title":"Targeting the ANG2\/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells","volume":"19","author":"Mazzieri","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188434","article-title":"Targeting tumor-associated macrophages for cancer immunotherapy","volume":"1874","author":"Shu","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA)-Reviews Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1479-5876-12-7","article-title":"The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma","volume":"12","author":"Wang","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119529_bib46","first-page":"1","article-title":"Neutrophils in the tumor microenvironment","author":"Wu","year":"2020","journal-title":"Tumor Microenviron. Hematop. CellsPart A"},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/carcin\/bgs123","article-title":"Tumor-associated neutrophils: friend or foe?","volume":"33","author":"Fridlender","year":"2012","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1134073","article-title":"Priming of neutrophils toward NETosis promotes tumor growth","volume":"5","author":"Demers","year":"2016","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.biopha.2026.119529_bib49","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1219828","article-title":"Peritumoral stromal neutrophils are essential for c-Met-elicited metastasis in human hepatocellular carcinoma","volume":"5","author":"He","year":"2016","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119529_bib51","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.12688\/f1000research.9691.1","article-title":"Recent advances in understanding neutrophils","volume":"5","author":"Deniset","year":"2016","journal-title":"F1000Research"},{"issue":"20","key":"10.1016\/j.biopha.2026.119529_bib52","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1007\/s00018-013-1286-4","article-title":"Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences","volume":"70","author":"Pillay","year":"2013","journal-title":"Cell. Mol. life Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119529_bib53","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","article-title":"Arginase I\u2013producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes","volume":"69","author":"Rodriguez","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1189\/jlb.0311177","article-title":"Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice","volume":"91","author":"Youn","year":"2012","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119529_bib55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib56","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib57","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4049\/jimmunol.0804253","article-title":"Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells","volume":"183","author":"Hanson","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119529_bib58","series-title":"Seminars in Immunology","article-title":"Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells","author":"Tumino","year":"2022"},{"issue":"25","key":"10.1016\/j.biopha.2026.119529_bib59","doi-asserted-by":"crossref","first-page":"37931","DOI":"10.18632\/oncotarget.9270","article-title":"Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma","volume":"7","author":"Binsfeld","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib60","doi-asserted-by":"crossref","first-page":"14979","DOI":"10.1038\/ncomms14979","article-title":"Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade","volume":"8","author":"Ouzounova","year":"2017","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2026.119529_bib61","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20100587","article-title":"HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.biopha.2026.119529_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303294","article-title":"Nanomedicine targeting myeloid-derived suppressor cells enhances anti-tumor immunity","volume":"13","author":"Yang","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib63","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.biopha.2026.119529_bib64","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41573-022-00413-7","article-title":"Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders","volume":"21","author":"Maskalenko","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14712598.2020.1688298","article-title":"NK cell-based therapeutics for lung cancer","volume":"20","author":"Pockley","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"issue":"35","key":"10.1016\/j.biopha.2026.119529_bib66","doi-asserted-by":"crossref","first-page":"17460","DOI":"10.1073\/pnas.1904253116","article-title":"Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation","volume":"116","author":"Schmidt","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","article-title":"Control of metastasis by NK cells","volume":"32","author":"L\u00f3pez-Soto","year":"2017","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001054","article-title":"Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions","volume":"8","author":"Russick","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib69","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41589-022-01017-3","article-title":"Lipid metabolism in T cell signaling and function","volume":"18","author":"Lim","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/25785826.2019.1698261","article-title":"Memory T cell, exhaustion, and tumor immunity","volume":"43","author":"Ando","year":"2020","journal-title":"Immunol. Med."},{"issue":"10","key":"10.1016\/j.biopha.2026.119529_bib71","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","article-title":"Metabolic and epigenetic regulation of T-cell exhaustion","volume":"2","author":"Franco","year":"2020","journal-title":"Nat. Metab."},{"issue":"10","key":"10.1016\/j.biopha.2026.119529_bib72","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.3390\/cells10102712","article-title":"Vascular endothelial cells: heterogeneity and targeting approaches","volume":"10","author":"Hennigs","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.biopha.2026.119529_bib73","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1369\/jhc.4A6514.2005","article-title":"Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues","volume":"54","author":"Pusztaszeri","year":"2006","journal-title":"J. Histochem. & Cytochem."},{"key":"10.1016\/j.biopha.2026.119529_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1367875","article-title":"Endothelial cells in tumor microenvironment: insights and perspectives","volume":"15","author":"Leone","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119529_bib75","first-page":"1553","article-title":"Endothelial cell protein C receptor: a multiliganded and multifunctional receptor. Blood","volume":"124","author":"Mohan Rao","year":"2014","journal-title":"J. Am. Soc. Hematol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119529_bib76","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0002-9440(10)64920-6","article-title":"Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors","volume":"160","author":"Morikawa","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"5482","key":"10.1016\/j.biopha.2026.119529_bib77","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","article-title":"Genes expressed in human tumor endothelium","volume":"289","author":"Croix","year":"2000","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biopha.2026.119529_bib78","doi-asserted-by":"crossref","first-page":"a006536","DOI":"10.1101\/cshperspect.a006536","article-title":"Tumor endothelial cells","volume":"2","author":"Dudley","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.biopha.2026.119529_bib79","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3389\/fcell.2020.00747","article-title":"Endothelial-to-mesenchymal transition in cancer","volume":"8","author":"Clere","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188608","article-title":"Pericytes cross-talks within the tumor microenvironment","volume":"1876","author":"Picoli","year":"2021","journal-title":"Biochimica et Biophysica Acta (BBA)-Reviews Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib81","first-page":"173","article-title":"Role of pericytes in angiogenesis: focus on cancer angiogenesis and anti-angiogenic therapy","volume":"63","author":"Chen","year":"2016","journal-title":"Neoplasma"},{"issue":"20","key":"10.1016\/j.biopha.2026.119529_bib82","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1158\/0008-5472.CAN-22-1695","article-title":"CD248 regulates Wnt signaling in pericytes to promote angiogenesis and tumor growth in lung cancer","volume":"82","author":"Hong","year":"2022","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.biopha.2026.119529_bib83","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1038\/s41418-021-00801-3","article-title":"RGS5\u2013TGF\u03b2\u2013Smad2\/3 axis switches pro-to anti-apoptotic signaling in tumor-residing pericytes, assisting tumor growth","volume":"28","author":"Dasgupta","year":"2021","journal-title":"Cell Death & Differ."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib84","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jcp.21222","article-title":"Impact of the non-cellular tumor microenvironment on metastasis: potential therapeutic and imaging opportunities","volume":"213","author":"Cretu","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2026.119529_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.818552","article-title":"Proteomic identification of a gastric tumor ECM signature associated with cancer progression","volume":"9","author":"Moreira","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib86","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41698-017-0045-7","article-title":"Vasodilator-stimulated phosphoprotein promotes liver metastasis of gastrointestinal cancer by activating a \u03b21-integrin-FAK-YAP1\/TAZ signaling pathway","volume":"2","author":"Xiang","year":"2018","journal-title":"NPJ Precis. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119529_bib87","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1039\/c5ib00040h","article-title":"Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration","volume":"7","author":"Acerbi","year":"2015","journal-title":"Integr. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib88","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40425-019-0556-6","article-title":"Collagen density regulates the activity of tumor-infiltrating T cells","volume":"7","author":"Kuczek","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"issue":"8","key":"10.1016\/j.biopha.2026.119529_bib90","doi-asserted-by":"crossref","first-page":"12173","DOI":"10.1002\/jcp.27955","article-title":"Transforming growth factor-\u03b2 signaling: tumorigenesis and targeting for cancer therapy","volume":"234","author":"Ahmadi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41232-019-0101-5","article-title":"The role of interleukin-1 in general pathology","volume":"39","author":"Kaneko","year":"2019","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.biopha.2026.119529_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2025.01.001","article-title":"Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy","author":"Wu","year":"2025","journal-title":"Cytokine & Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib93","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1158\/0008-5472.CAN-10-4627","article-title":"Interleukin-10 ablation promotes tumor development, growth, and metastasis","volume":"72","author":"Tanikawa","year":"2012","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib94","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1067\/msy.2002.125352","article-title":"Production of interferon-gamma by tumor-sensitized T cells is essential for interleukin-12\u2013induced complete tumor eradication","volume":"132","author":"Lee","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.biopha.2026.119529_bib95","article-title":"m6A RNA modification in tumor-associated macrophages: emerging roles in cancer immunity","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib96","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.biopha.2026.119529_bib97","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3390\/cancers14081947","article-title":"Platelet-derived PDGFB promotes recruitment of cancer-associated fibroblasts, deposition of extracellular matrix and Tgf\u03b2 signaling in the tumor microenvironment","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib98","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13045-020-01030-w","article-title":"Targeting hypoxic tumor microenvironment in pancreatic cancer","volume":"14","author":"Tao","year":"2021","journal-title":"J. Hematol. & Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib99","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2026.119529_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2025.101626","article-title":"For and against tumor microenvironment: nanoparticle-based strategies for active cancer therapy","author":"Karimi","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib101","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10555-019-09796-3","article-title":"Acidosis and proteolysis in the tumor microenvironment","volume":"38","author":"Ji","year":"2019","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2026.119529_bib102","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/cell.2023.0010","article-title":"Functions of key enzymes of glycolytic metabolism in tumor microenvironment","volume":"25","author":"Xu","year":"2023","journal-title":"Cell. Reprogramming"},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib103","first-page":"5865","article-title":"The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis","volume":"14","author":"Li","year":"2017","journal-title":"Oncol. Lett."},{"issue":"10","key":"10.1016\/j.biopha.2026.119529_bib104","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrc1949","article-title":"Multifunctional enzymes in cancer","volume":"6","author":"Mohamed","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119529_bib105","first-page":"440","article-title":"Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy","volume":"31","author":"Sharma","year":"2024","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib106","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s42255-023-00963-z","article-title":"Metabolic heterogeneity in cancer","volume":"6","author":"Demicco","year":"2024","journal-title":"Nat. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib107","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.critrevonc.2003.09.001","article-title":"The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, eg acute leukemia","volume":"50","author":"Klein","year":"2004","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119529_bib108","doi-asserted-by":"crossref","first-page":"E1142","DOI":"10.1073\/pnas.1521265113","article-title":"Tailoring nanoparticle designs to target cancer based on tumor pathophysiology","volume":"113","author":"Sykes","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119529_bib109","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41388-022-02547-9","article-title":"Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance","volume":"42","author":"Fattore","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119529_bib110","article-title":"HIF1\u03b1 integrates lipogenic FASN and glycolytic GLUT3 to overcome intratumor oxidative and","author":"Wang","year":"2025","journal-title":"Hypoxic Stress Colorectal Cancer Metastas-.-."},{"issue":"44","key":"10.1016\/j.biopha.2026.119529_bib111","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1021\/acs.langmuir.0c02446","article-title":"Investigation of pH-responsiveness inside lipid nanoparticles for parenteral mRNA application using small-angle X-ray scattering","volume":"36","author":"Uebbing","year":"2020","journal-title":"Langmuir"},{"key":"10.1016\/j.biopha.2026.119529_bib112","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jconrel.2020.02.040","article-title":"Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy","volume":"321","author":"Yu","year":"2020","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.biopha.2026.119529_bib113","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acs.molpharmaceut.0c00247","article-title":"Targeting the tumor core: hypoxia-responsive nanoparticles for the delivery of chemotherapy to pancreatic tumors","volume":"17","author":"Confeld","year":"2020","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib114","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s42003-020-0817-4","article-title":"pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics","volume":"3","author":"Palanikumar","year":"2020","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12943-025-02435-2","article-title":"Advances in PLGA-based polymeric nanocarriers for colorectal cancer therapy: overcoming chemoresistance through controlled delivery strategies","volume":"24","author":"Khan","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2026.119529_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120533","article-title":"A self-activating nanovesicle with oxygen-depleting capability for efficient hypoxia-responsive chemo-thermo cancer therapy","volume":"269","author":"Chen","year":"2021","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biopha.2026.119529_bib117","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1021\/acsnano.6b02231","article-title":"Gold nanoparticle reprograms pancreatic tumor microenvironment and inhibits tumor growth","volume":"10","author":"Saha","year":"2016","journal-title":"ACS nano"},{"issue":"38","key":"10.1016\/j.biopha.2026.119529_bib118","doi-asserted-by":"crossref","first-page":"13639","DOI":"10.1021\/ja902062j","article-title":"pH-induced aggregation of gold nanoparticles for photothermal cancer therapy","volume":"131","author":"Nam","year":"2009","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.biopha.2026.119529_bib119","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/pharmaceutics14040847","article-title":"Improving tirapazamine (TPZ) to target and eradicate hypoxia tumors by gold nanoparticle carriers","volume":"14","author":"Ajnai","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.biopha.2026.119529_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108592","article-title":"Chemo\u2013immunotherapy for chemo-resistance and metastasis of triple-negative breast cancer by combination of iron-oxide nanoparticles and dual-targeting doxorubicin liposomes","volume":"34","author":"Hu","year":"2023","journal-title":"Chin. Chem. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib121","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12645-024-00266-2","article-title":"Black TiO2-based nanoparticles as toll-like receptor stimulator delivery system for enhanced photothermal-immunotherapy of pancreatic cancer","volume":"15","author":"Xu","year":"2024","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.biopha.2026.119529_bib122","doi-asserted-by":"crossref","first-page":"14753","DOI":"10.2147\/IJN.S531731","article-title":"RGD-modified gold nanoparticles loaded with SAHA remodel the hypoxic inflammatory microenvironment via inhibiting HIF-1\u03b1-VEGF signaling to enhance radiosensitivity in NSCLC","author":"Lin","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.biopha.2026.119529_bib123","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nnano.2017.113","article-title":"Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy","volume":"12","author":"Min","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib124","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12951-024-02744-6","article-title":"Tumor targeting peptide TMTP1 modified Antigen capture Nano-vaccine combined with chemotherapy and PD-L1 blockade effectively inhibits growth of ovarian cancer","volume":"22","author":"Zhou","year":"2024","journal-title":"J. nanobiotechnology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib125","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/s41467-023-39035-x","article-title":"Nanovesicles loaded with a TGF-\u03b2 receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib126","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12951-021-01085-y","article-title":"Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer","volume":"19","author":"Zhang","year":"2021","journal-title":"J. nanobiotechnology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib127","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1038\/s41467-024-54877-9","article-title":"Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity","volume":"15","author":"Hamouda","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2026.119529_bib128","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1039\/D0NH00588F","article-title":"Tumor-targeted gene therapy with lipid nanoparticles inhibits tumor-associated adipocytes and remodels the immunosuppressive tumor microenvironment in triple-negative breast cancer","volume":"6","author":"Liu","year":"2021","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.biopha.2026.119529_bib129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biomaterials.2016.09.034","article-title":"Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment","volume":"112","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2026.119529_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1334800","article-title":"Polymeric nanocapsules loaded with poly (I: C) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors","volume":"14","author":"Anfray","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib131","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1038\/s41467-025-59840-w","article-title":"Integrating antigen capturing nanoparticles and type 1 conventional dendritic cell therapy for in situ cancer immunization","volume":"16","author":"Chao","year":"2025","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2026.119529_bib132","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.mattod.2017.11.022","article-title":"Metallic nanoparticles for cancer immunotherapy","volume":"21","author":"Evans","year":"2018","journal-title":"Mater. Today"},{"key":"10.1016\/j.biopha.2026.119529_bib133","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jconrel.2015.10.016","article-title":"CpG expedites regression of local and systemic tumors when combined with activatable nanodelivery","volume":"220","author":"Kheirolomoom","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119529_bib134","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biomaterials.2018.08.064","article-title":"A novel galactose-PEG-conjugated biodegradable copolymer is an efficient gene delivery vector for immunotherapy of hepatocellular carcinoma","volume":"184","author":"Liu","year":"2018","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib135","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1038\/s41467-020-18626-y","article-title":"Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis","volume":"11","author":"Rao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119529_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122866","article-title":"Reprogramming of tumor-associated macrophages by polyaniline-coated iron oxide nanoparticles applied to treatment of breast cancer","volume":"636","author":"Nascimento","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2026.119529_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308254","article-title":"Tumor microenvironment modulating CaCO3-based colloidosomal microreactors can generally reinforce cancer immunotherapy","volume":"36","author":"Dong","year":"2024","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.biopha.2026.119529_bib138","doi-asserted-by":"crossref","first-page":"12295","DOI":"10.1021\/acsnano.4c01229","article-title":"Genetically edited cascade nanozymes for cancer immunotherapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS nano"},{"issue":"10","key":"10.1016\/j.biopha.2026.119529_bib139","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1021\/acsnano.6b02776","article-title":"The binding site barrier elicited by tumor-associated fibroblasts interferes disposition of nanoparticles in stroma-vessel type tumors","volume":"10","author":"Miao","year":"2016","journal-title":"ACS nano"},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib140","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1021\/acsnano.7b01522","article-title":"Quercetin remodels the tumor microenvironment to improve the permeation, retention, and antitumor effects of nanoparticles","volume":"11","author":"Hu","year":"2017","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2026.119529_bib141","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.2147\/IJN.S418100","article-title":"Co-delivery nanomicelles for potentiating TNBC immunotherapy by synergetically reshaping CAFs-mediated tumor stroma and reprogramming immunosuppressive microenvironment","author":"Zhang","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119529_bib142","first-page":"126","article-title":"CRCs-CAFs crosstalk-targeted nano-delivery system reprograms tumor microenvironment for oxaliplatin resistance reversing and liver metastasis inhibition in colorectal cancer","volume":"54","author":"Liu","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biopha.2026.119529_bib143","article-title":"Precision targeted cancer-associated fibroblast nano-regulator enhanced chemo-immunotherapy for triple-negative breast cancer","author":"Xian","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2026.119529_bib144","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.biomaterials.2017.08.009","article-title":"Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer","volume":"144","author":"Hu","year":"2017","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib145","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1021\/acs.nanolett.6b04150","article-title":"Protein nanocage mediated fibroblast-activation protein targeted photoimmunotherapy to enhance cytotoxic T cell infiltration and tumor control","volume":"17","author":"Zhen","year":"2017","journal-title":"Nano Lett."},{"issue":"47","key":"10.1016\/j.biopha.2026.119529_bib146","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004853","article-title":"Activating macrophage-mediated cancer immunotherapy by genetically edited nanoparticles","volume":"32","author":"Rao","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119529_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116951","article-title":"Recent advances in biomimetic cell membrane\u2013camouflaged nanoparticles for cancer therapy","volume":"177","author":"Alimohammadvand","year":"2024","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.biopha.2026.119529_bib148","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.intimp.2016.06.006","article-title":"Noble metal nanoparticle-induced oxidative stress modulates tumor associated macrophages (TAMs) from an M2 to M1 phenotype: An in vitro approach","volume":"38","author":"Pal","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib149","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","article-title":"situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib150","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1038\/s41467-023-42972-2","article-title":"Nanomedicine-based co-delivery of a calcium channel inhibitor and a small molecule targeting CD47 for lung cancer immunotherapy","volume":"14","author":"Guo","year":"2023","journal-title":"Nat. Commun."},{"issue":"27","key":"10.1016\/j.biopha.2026.119529_bib151","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1002\/adfm.201501283","article-title":"Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumor-associated macrophages and cancer cells","volume":"25","author":"Conde","year":"2015","journal-title":"Adv. Funct. Mater."},{"issue":"27","key":"10.1016\/j.biopha.2026.119529_bib152","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201701021","article-title":"Photosensitization priming of tumor microenvironments improves delivery of nanotherapeutics via neutrophil infiltration","volume":"29","author":"Chu","year":"2017","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib153","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/s41467-023-37872-4","article-title":"CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy","volume":"14","author":"Chang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119529_bib154","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.5c14907","article-title":"Transporting via neutrophil as a key mechanism for nanoparticle redistribution to tumor and spleen","author":"Wang","year":"2025","journal-title":"ACS nano"},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12951-024-02726-8","article-title":"Repolarizing neutrophils via MnO2 nanoparticle-activated STING pathway enhances Salmonella-mediated tumor immunotherapy","volume":"22","author":"Lu","year":"2024","journal-title":"J. Nanobiotechnology"},{"issue":"9","key":"10.1016\/j.biopha.2026.119529_bib156","doi-asserted-by":"crossref","first-page":"15471","DOI":"10.1021\/acsnano.2c08013","article-title":"Immunogenic cell death augmented by manganese zinc sulfide nanoparticles for metastatic melanoma immunotherapy","volume":"16","author":"Li","year":"2022","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2026.119529_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121856","article-title":"Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy","volume":"290","author":"Cao","year":"2022","journal-title":"Biomaterials"},{"issue":"37","key":"10.1016\/j.biopha.2026.119529_bib158","doi-asserted-by":"crossref","first-page":"eaau6584","DOI":"10.1126\/sciimmunol.aau6584","article-title":"Engineering nanoparticles to locally activate T cells in the tumor microenvironment","volume":"4","author":"Wang","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biopha.2026.119529_bib159","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jconrel.2022.10.002","article-title":"Glycosylation of OVA antigen-loaded PLGA nanoparticles enhances DC-targeting for cancer vaccination","volume":"351","author":"Chou","year":"2022","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib160","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1021\/acs.nanolett.8b04296","article-title":"Nanoenabled modulation of acidic tumor microenvironment reverses anergy of infiltrating T cells and potentiates anti-PD-1 therapy","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"issue":"21","key":"10.1016\/j.biopha.2026.119529_bib161","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202200909","article-title":"Ovalbumin and poly (i: c) encapsulated dendritic cell-targeted nanoparticles for immune activation in the small intestinal lymphatic system","volume":"11","author":"Kim","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib162","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202201569","article-title":"Pre-induced ICD membrane-coated carrier-free nanoparticles for the personalized lung cancer immunotherapy","volume":"7","author":"Li","year":"2023","journal-title":"Small Methods"},{"issue":"6","key":"10.1016\/j.biopha.2026.119529_bib163","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202412","article-title":"Antitumor activity of anti-miR-21 delivered through lipid nanoparticles","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"18","key":"10.1016\/j.biopha.2026.119529_bib164","doi-asserted-by":"crossref","first-page":"10009","DOI":"10.3390\/ijms221810009","article-title":"Nanoparticles targeting innate immune cells in tumor microenvironment","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119529_bib165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119529_bib166","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1084\/jem.20050715","article-title":"Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma","volume":"202","author":"Rodriguez","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib167","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","article-title":"Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives","volume":"222","author":"Rodr\u00edguez","year":"2008","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2026.119529_bib168","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1609","article-title":"Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer","volume":"13","author":"Nagaraj","year":"2007","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119529_bib169","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.4049\/jimmunol.175.7.4583","article-title":"Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells","volume":"175","author":"Kusmartsev","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119529_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122533","article-title":"MDSC-targeting gold nanoparticles enhance PD-1 tumor immunotherapy by inhibiting NLRP3 inflammasomes","volume":"307","author":"Zhu","year":"2024","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.biopha.2026.119529_bib171","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1039\/D0NR00080A","article-title":"Dual photothermal MDSCs-targeted immunotherapy inhibits lung immunosuppressive metastasis by enhancing T-cell recruitment","volume":"12","author":"Domvri","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2026.119529_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120666","article-title":"Cargo-free immunomodulatory nanoparticles combined with anti-PD-1 antibody for treating metastatic breast cancer","volume":"269","author":"Zhang","year":"2021","journal-title":"Biomaterials"},{"issue":"42","key":"10.1016\/j.biopha.2026.119529_bib173","doi-asserted-by":"crossref","first-page":"eady4135","DOI":"10.1126\/sciadv.ady4135","article-title":"Nanoparticle-boosted myeloid-derived suppressor cell therapy for immune reprogramming in multiple sclerosis","volume":"11","author":"Zhang","year":"2025","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.biopha.2026.119529_bib174","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/cells12030503","article-title":"Targeting human endothelial cells with glutathione and alanine increases the crossing of a polypeptide nanocarrier through a blood\u2013brain barrier model and entry to human brain organoids","volume":"12","author":"M\u00e9sz\u00e1ros","year":"2023","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.biopha.2026.119529_bib175","doi-asserted-by":"crossref","first-page":"14348","DOI":"10.1021\/acsnano.4c00480","article-title":"Precise modulation of pericyte dysfunction by a multifunctional nanoprodrug to ameliorate Alzheimer\u2019s disease","volume":"18","author":"Yang","year":"2024","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2026.119529_bib176","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2024.03.047","article-title":"Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood\u2013tumor barrier for boosted brain tumor therapy","volume":"369","author":"Mu","year":"2024","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.biopha.2026.119529_bib177","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/j.biomaterials.2013.12.027","article-title":"Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis","volume":"35","author":"Guan","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2026.119529_bib178","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.actbio.2023.12.040","article-title":"Nano-induced endothelial leakiness-reversing nanoparticles for targeting, penetration and restoration of endothelial cell barrier","volume":"175","author":"Huang","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2026.119529_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.587012","article-title":"Nanoparticle surface functionalization: how to improve biocompatibility and cellular internalization","volume":"7","author":"Sanit\u00e0","year":"2020","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.biopha.2026.119529_bib180","doi-asserted-by":"crossref","DOI":"10.34133\/bmr.0289","article-title":"Engineering nanoparticles to modulate extracellular matrix and immune components of the tumor microenvironment in cancer immunotherapy","author":"Dang","year":"2025","journal-title":"Biomater. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib181","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2026.119529_bib182","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1021\/acsnano.7b00781","article-title":"Transformable nanomaterials as an artificial extracellular matrix for inhibiting tumor invasion and metastasis","volume":"11","author":"Hu","year":"2017","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2026.119529_bib183","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","article-title":"Extracellular matrix in the tumor microenvironment and its impact on cancer therapy","volume":"6","author":"Henke","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119529_bib184","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1021\/acs.nanolett.6b00820","article-title":"Hyaluronidase embedded in nanocarrier PEG shell for enhanced tumor penetration and highly efficient antitumor efficacy","volume":"16","author":"Zhou","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2026.119529_bib185","article-title":"Tumor extracellular matrix modulating strategies for enhanced antitumor therapy of nanomedicines","volume":"16","author":"Li","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib186","first-page":"265","article-title":"Increased nanoparticle penetration in collagenase-treated multicellular spheroids","volume":"2","author":"Goodman","year":"2007","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib187","doi-asserted-by":"crossref","first-page":"126","DOI":"10.7150\/thno.29431","article-title":"Engineering nanoparticles for targeted remodeling of the tumor microenvironment to improve cancer immunotherapy","volume":"9","author":"Gao","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119529_bib188","article-title":"Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119529_bib189","doi-asserted-by":"crossref","first-page":"10509","DOI":"10.1021\/acsnano.3c12064","article-title":"Iron oxide nanoparticles inhibit tumor progression and suppress lung metastases in mouse models of breast cancer","volume":"18","author":"Korangath","year":"2024","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2026.119529_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1614640","article-title":"Modulation of the immune microenvironment using nanomaterials: a new strategy for tumor immunotherapy","volume":"16","author":"Piao","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib191","doi-asserted-by":"crossref","first-page":"29308","DOI":"10.1038\/s41598-025-14704-7","article-title":"Dual-loaded niosome-dendrimer nanoplatform enhances Tirapazamine delivery to hypoxic breast cancer cells","volume":"15","author":"Kaveh Zenjanab","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib192","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/acsnano.5b06779","article-title":"Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumor-associated macrophages toward M1-like phenotype and attenuating tumor hypoxia","volume":"10","author":"Song","year":"2016","journal-title":"ACS nano"},{"issue":"29","key":"10.1016\/j.biopha.2026.119529_bib193","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1016\/j.biomaterials.2012.06.059","article-title":"Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells","volume":"33","author":"Chen","year":"2012","journal-title":"Biomaterials"},{"issue":"33","key":"10.1016\/j.biopha.2026.119529_bib194","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1002\/adma.201601902","article-title":"Intelligent albumin-MnO2 nanoparticles as pH-\/H2 O2-responsive dissociable nanocarriers to modulate tumor hypoxia for effective combination therapy","volume":"28","author":"Chen","year":"2016","journal-title":"Adv. Mater. (Deerfield Beach Fla. )"},{"issue":"28","key":"10.1016\/j.biopha.2026.119529_bib195","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201801120","article-title":"A multifunctional biomimetic nanoplatform for relieving hypoxia to enhance chemotherapy and inhibit the PD-1\/PD-L1 axis","volume":"14","author":"Zou","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.biopha.2026.119529_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102373","article-title":"Blockade of HIF-1\u03b1 and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth","volume":"34","author":"Budi","year":"2021","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"19","key":"10.1016\/j.biopha.2026.119529_bib197","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/1873-3468.12784","article-title":"Immunosuppressive enzymes in the tumor microenvironment","volume":"591","author":"Molinier-Frenkel","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2026.119529_bib198","first-page":"1","article-title":"Immune checkpoint inhibitors and immunosuppressive tumor microenvironment: current challenges and strategies to overcome resistance","author":"Gill","year":"2025","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119529_bib199","doi-asserted-by":"crossref","first-page":"20400","DOI":"10.1021\/acsnano.2c06646","article-title":"Tumor microenvironment-activable manganese-boosted catalytic immunotherapy combined with PD-1 checkpoint blockade","volume":"16","author":"Zhao","year":"2022","journal-title":"ACS nano"},{"issue":"3","key":"10.1016\/j.biopha.2026.119529_bib200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10787-010-0073-1","article-title":"Lysyl oxidase: a potential target for cancer therapy","volume":"19","author":"Siddikuzzaman","year":"2011","journal-title":"Inflammopharmacology"},{"issue":"6","key":"10.1016\/j.biopha.2026.119529_bib201","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1021\/nl301206p","article-title":"Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix","volume":"12","author":"Kanapathipillai","year":"2012","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib202","doi-asserted-by":"crossref","DOI":"10.1049\/2024\/5593879","article-title":"Cancer vaccines designed based the nanoparticle and tumor cells for the treatment of tumors: a perspective","volume":"2024","author":"Wu","year":"2024","journal-title":"IET nanobiotechnology"},{"key":"10.1016\/j.biopha.2026.119529_bib203","first-page":"345","article-title":"STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy","volume":"42","author":"Nguyen","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biopha.2026.119529_bib204","article-title":"Clinical trials of nanoparticle-enhanced CAR-T and NK cell therapies in oncology: overcoming translational and clinical challenges-a mini review","volume":"12","author":"Zhao","year":"2025","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib205","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40164-025-00656-1","article-title":"Developments in nanotechnology approaches for the treatment of solid tumors","volume":"14","author":"Venturini","year":"2025","journal-title":"Exp. Hematol. & Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib206","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cellimm.2010.03.001","article-title":"Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice","volume":"263","author":"Pfannenstiel","year":"2010","journal-title":"Cell. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119529_bib207","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00262-018-2221-1","article-title":"Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1\u2013CH3 fusion protein","volume":"67","author":"Pan","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib208","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","volume":"35","author":"Beg","year":"2017","journal-title":"Investig. N. Drugs"},{"issue":"9","key":"10.1016\/j.biopha.2026.119529_bib209","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12032-017-1009-z","article-title":"Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma","volume":"34","author":"Graziani","year":"2017","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2026.119529_bib210","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.2523","article-title":"A phase 1, open-label, multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in subjects with resected solid tumors and in combination with pembrolizumab in subjects with unresectable solid tumors (Keynote-603)","author":"Burris III","year":"2019","journal-title":"Am. Soc. Clin. Oncol."},{"issue":"7607","key":"10.1016\/j.biopha.2026.119529_bib211","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"issue":"599","key":"10.1016\/j.biopha.2026.119529_bib212","doi-asserted-by":"crossref","first-page":"eaba9772","DOI":"10.1126\/scitranslmed.aba9772","article-title":"Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models","volume":"13","author":"Lin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119529_bib213","article-title":"Targeted nanoparticles show success in clinical trials in","author":"Trafton","year":"2012","journal-title":"Nanowerk N."},{"issue":"11","key":"10.1016\/j.biopha.2026.119529_bib214","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00109-011-0785-8","article-title":"Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo","volume":"89","author":"Zachar","year":"2011","journal-title":"J. Mol. Med."},{"issue":"36","key":"10.1016\/j.biopha.2026.119529_bib215","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1200\/JCO.2013.55.0376","article-title":"First-in-human phase I study of the liposomal RNA interference therapeutic Atu027 in patients with advanced solid tumors","volume":"32","author":"Schultheis","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119529_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101533","article-title":"Stroma-targeted nanoparticles that remodel stromal alignment to enhance drug delivery and improve the antitumor efficacy of Nab-paclitaxel in pancreatic ductal adenocarcinoma models","volume":"45","author":"Wei","year":"2022","journal-title":"Nano Today"},{"issue":"8_ement","key":"10.1016\/j.biopha.2026.119529_bib217","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/1538-7445.AM2011-1306","article-title":"A Phase 1b\/2a study of CRLX101, a novel nanopharmaceutical of camptothecin, in solid tumor cancer patients who have failed standard therapy","volume":"71","author":"Weiss","year":"2011","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119529_bib218","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/ijms23031685","article-title":"Nanoparticles in clinical translation for cancer therapy","volume":"23","author":"Mundekkad","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119529_bib219","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"16","author":"Patel","year":"2025","journal-title":"IJSAT-Int. J. Sci. Technol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119529_bib220","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","author":"Hua","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119529_bib221","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of clinical translation of cancer nanomedicines\u2014lessons learned from successes and failures","volume":"52","author":"He","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2026.119529_bib222","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2025.1002308","article-title":"Nanoimmunotherapy: the smart trooper for cancer therapy","volume":"6","author":"Parveen","year":"2025","journal-title":"Explor. Target. Anti-Tumor Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib223","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209260120","article-title":"Extracellular matrix physical properties govern the diffusion of nanoparticles in tumor microenvironment","volume":"120","author":"He","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib224","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.nano.2012.07.002","article-title":"Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure","volume":"9","author":"Torosean","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib225","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-025-02357-z","article-title":"Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery","volume":"24","author":"Sabit","year":"2025","journal-title":"Mol. Cancer"},{"issue":"13","key":"10.1016\/j.biopha.2026.119529_bib226","doi-asserted-by":"crossref","first-page":"eaay1601","DOI":"10.1126\/sciadv.aay1601","article-title":"Nanoparticle interactions with immune cells dominate tumor retention and induce T cell\u2013mediated tumor suppression in models of breast cancer","volume":"6","author":"Korangath","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.biopha.2026.119529_bib227","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnci\/djab157","article-title":"Clinical implications of inter-and intratumor heterogeneity of immune cell markers in lung cancer","volume":"114","author":"Zhao","year":"2022","journal-title":"JNCI Journal National Cancer Institute"},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib228","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41565-020-00817-9","article-title":"Considerations for designing preclinical cancer immune nanomedicine studies","volume":"16","author":"Jiang","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119529_bib229","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1021\/acsnano.2c08451","article-title":"Radiolabeled biodistribution of expansile nanoparticles: intraperitoneal administration results in tumor specific accumulation","volume":"17","author":"Colby","year":"2023","journal-title":"ACS nano"},{"issue":"10","key":"10.1016\/j.biopha.2026.119529_bib230","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjugate Chem."},{"issue":"6","key":"10.1016\/j.biopha.2026.119529_bib231","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/acs.bioconjchem.7b00237","article-title":"Intraperitoneal administration of neural stem cell\u2013nanoparticle conjugates targets chemotherapy to ovarian tumors","volume":"28","author":"Cao","year":"2017","journal-title":"Bioconjugate Chem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119529_bib232","doi-asserted-by":"crossref","first-page":"L400","DOI":"10.1152\/ajplung.00041.2008","article-title":"Pulmonary applications and toxicity of engineered nanoparticles","volume":"295","author":"Card","year":"2008","journal-title":"Am. J. Physiol. -Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119529_bib233","article-title":"Immunomodulation of nanoparticles in nanomedicine applications","volume":"2014","author":"Jiao","year":"2014","journal-title":"BioMed. Res. Int."},{"issue":"27","key":"10.1016\/j.biopha.2026.119529_bib234","article-title":"Photo-enhanced synergistic induction of ferroptosis for anti-cancer immunotherapy","volume":"12","author":"Zhou","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.biopha.2026.119529_bib235","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3934\/bioeng.2024026","article-title":"Harnessing artificial intelligence for enhanced nanoparticle design in precision oncology","volume":"11","author":"Sheikh","year":"2024","journal-title":"AIMS Bioeng."},{"issue":"10","key":"10.1016\/j.biopha.2026.119529_bib236","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202104885","article-title":"Evoking highly immunogenic ferroptosis aided by intramolecular motion-induced photo-hyperthermia for cancer therapy","volume":"9","author":"Chen","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2026.119529_bib237","article-title":"Single-cell RNA sequencing reveals tumor immune microenvironment in human hypopharygeal squamous cell carcinoma and lymphatic metastasis","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:42:56Z","timestamp":1787438576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226005652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":237,"alternative-id":["S0753332226005652"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119529","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle-based strategies for immune modulation and reorganization in the tumor microenvironment to combat cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119529"}}